Presentation CTO 2023 How Do the Coronary Revascularization Clinical Trials Apply to the Patient in Front of Me? Presenter: Ajay Kirtane February 23, 2023 REGISTER for free or LOG IN to view this content Coronary Presentation CTO 2023 Up Next Presentation CTO 2023 Effect of Percutaneous Coronary Intervention on Reduce Metalloproteinase 9 (MMP-9), Soluble Suppression of Tumorigenicity 2 (sST2), N Terminal Pro B-Type Natriuretic Peptides (NT Pro BNP) and Anginal Component in Quality of Life of Chronic Total… Presenter: I Made Junior Rina Artha February 23, 2023 More slides + Presentation CTO 2023 Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention After a Prior Failed Attempt Presenter: Athanasios Rempakos February 23, 2023 Presentation CTO 2023 Dual Guidewire Balloon Antegrade Fenestration and Re-entry Technique for Coronary Chronic Total Occlusions Percutaneous Coronary Interventions Presenter: Alfredo R. Galassi February 23, 2023 We Recommend
Presentation CTO 2023 Effect of Percutaneous Coronary Intervention on Reduce Metalloproteinase 9 (MMP-9), Soluble Suppression of Tumorigenicity 2 (sST2), N Terminal Pro B-Type Natriuretic Peptides (NT Pro BNP) and Anginal Component in Quality of Life of Chronic Total… Presenter: I Made Junior Rina Artha February 23, 2023
Presentation CTO 2023 Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention After a Prior Failed Attempt Presenter: Athanasios Rempakos February 23, 2023
Presentation CTO 2023 Dual Guidewire Balloon Antegrade Fenestration and Re-entry Technique for Coronary Chronic Total Occlusions Percutaneous Coronary Interventions Presenter: Alfredo R. Galassi February 23, 2023